Article

The efficacy of omalizumab treatment in patients with non-atopic severe asthma

2022-01-31

Abstract excerpt

<h4>Introduction</h4> Non-atopic asthmatic patients generally have more severe clinical manifestations frequently accompanied by chronic sinusitis and nasal polyps, with more limited therapeutic options as compared to atopic asthmatic patients. This has led to a search for novel therapeutic approaches including omalizumab for non-atopic asthmatic patients who are not adequately controlled with current therapies. <...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6ac223de-7f2f-5e81-97c1-0e9cc10325eb
DOI: 10.1101/2022.01.29.22270075

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The efficacy of omalizumab treatment in patients with non-atopic severe asthmaDOI 10.1101/2022.01.29.22270075Read

Influence of effective omalizumab treatment on eosinophils in allergic asthma with comorbiditiesSemantic proximity Read

Efficacy and Safety of Add-On Omalizumab in 4-6-Year-Old Children with Uncontrolled Allergic Asthma: A 52-Week Retrospective StudySemantic proximity Read

Omalizumab for the Treatment of Allergic Rhinitis: A Systematic Review and Meta-AnalysisSemantic proximity Read

Mepolizumab real-world effectiveness in severe asthma with an eosinophilic phenotype and overlapping severe allergic asthma.Semantic proximity Read

Clinical Experience with Anti-IgE Monoclonal Antibody (Omalizumab) In Paediatric Severe Allergic Asthma – A Romanian PerspectiveSemantic proximity Read

Effectiveness of mepolizumab in a real-life cohort of patients with severe refractory eosinophilic asthma and multiple comorbiditiesSemantic proximity Read

Severe asthma phenotypes in patients controlled with omalizumab: A real-world study.Semantic proximity Read

Influence of Genetics on the Response to Omalizumab in Patients with Severe Uncontrolled Asthma with an Allergic Phenotype.Semantic proximity Read

Clinical characteristics and biological treatment responses of patients with late-onset asthma phenotype.Semantic proximity Read

Real-world Omalizumab and Mepolizumab treated difficult asthma phenotypes and their clinical outcomes.Semantic proximity Read

Clinical Recommendations for the Management of Biological Treatments in Severe Asthma Patients: A Consensus Statement.Semantic proximity Read

Current treatment of severe asthma.Semantic proximity Read